Vo Tuan, Nguyen Duy, Ho Thang, Tran Hoang, Nguyen Dat, Bui Thuong, Cao Thinh, Vo Brian
Senior Attending OB-GYN Physician at Ho Chi Minh City, Vietnam.
Resident OB-GYN Physician, University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam.
Gynecol Minim Invasive Ther. 2024 Sep 7;13(4):247-252. doi: 10.4103/gmit.gmit_110_23. eCollection 2024 Oct-Dec.
This study aimed to determine the recurrence rate and related risk factors of primary fallopian tube cancer (PFTC).
We conducted a retrospective study of 47 patients with histopathological diagnosis of PFTC treated at Tu Du Hospital between January 1, 2015, and July 31, 2022. The cumulative recurrence rate was estimated using the life table method, and recurrence-associated factors were determined using the Log-rank test and Cox proportional hazard model.
The median follow-up period was 40 months (range, 7-96 months). Eight patients (17.0%) experienced recurrence. The cumulative recurrence rate of PFTC patients at 12 months was 4.4% (95% confidence interval [95% CI]: 1.12-16.45), at 24 months was 9.1% (95% CI: 3.52-22.5), at 36 months was 14.9% (95% CI: 6.92-30.41), at 48 months was 19.3% (95% CI: 9.35-37.24), and at 60 months was 25.7% (95% CI: 12.68-47.88). A higher recurrence rate was significantly associated with elevated pretreatment CA 125 level (<35 U/mL vs. ≥35 U/mL, hazards ratio [HR] = 36.9, 95% CI: 1.47-921.37), advanced FIGO stages (Stage I-II vs. stages III, HR = 6.61, 95% CI: 1.18-36.93), and suboptimal debulking surgery (residual disease ≤1 cm vs. residual disease >1 cm, HR = 7.52, 95% CI: 1.47-38.49).
The overall recurrence rate of PFTC patients in Southern Vietnam was 17.0%. Appropriate follow-up strategies for patients with high-risk factors are needed for early detection and management of recurrence.
本研究旨在确定原发性输卵管癌(PFTC)的复发率及相关危险因素。
我们对2015年1月1日至2022年7月31日期间在涂都医院接受治疗且经组织病理学诊断为PFTC的47例患者进行了回顾性研究。采用寿命表法估计累积复发率,并使用Log-rank检验和Cox比例风险模型确定复发相关因素。
中位随访期为40个月(范围7 - 96个月)。8例患者(17.0%)出现复发。PFTC患者在12个月时的累积复发率为4.4%(95%置信区间[95%CI]:1.12 - 16.45),24个月时为9.1%(95%CI:3.52 - 22.5),36个月时为14.9%(95%CI:6.92 - 30.41),48个月时为19.3%(95%CI:9.35 - 37.24),60个月时为25.7%(95%CI:12.68 - 47.88)。较高的复发率与术前CA 125水平升高显著相关(<35 U/mL与≥35 U/mL相比,风险比[HR]=36.9,95%CI:1.47 - 921.37)、国际妇产科联盟(FIGO)分期较晚(I - II期与III期相比,HR = 6.61,95%CI:1.18 - 36.93)以及减瘤手术效果欠佳(残留病灶≤1 cm与残留病灶>1 cm相比,HR = 7.52,95%CI:1.47 - 38.49)有关。
越南南部PFTC患者的总体复发率为17.0%。需要对具有高危因素的患者采取适当的随访策略,以便早期发现和处理复发情况。